Back
Actinium Pharmaceuticals Stock Predictions
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
ATNM
Actinium Pharmaceuticals
Last Price:
$1.19
Seasonality Move:
5.17%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Actinium Pharmaceuticals Stock Forecast
-
Is Actinium Pharmaceuticals Stock Undervalued?The current Actinium Pharmaceuticals [ATNM] share price is $1.30. The Score for ATNM is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ATNM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Actinium Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Actinium Pharmaceuticals Stock Rating
Data Unavailable
Actinium Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
actiniumpharma.com
52-Week Data
52-Week High:
10.24
52-Week Low:
1.03
Prediction Charts
Market Cap:
40.6M
Price in USD:
1.30
Volume:
187.7K
Beta:
0.71
Technical Analysis
SMA50:
1.21
SMA100:
1.36
SMA200:
2.96
52-Wk Change:
-80.74%
Stock Predictions
-
Is Actinium Pharmaceuticals stock public?Yes, Actinium Pharmaceuticals is a publicly traded company.
-
What is the Actinium Pharmaceuticals stock quote today?The Actinium Pharmaceuticals stock price is 1.30 USD today.
-
How to buy Actinium Pharmaceuticals stock online?You can buy Actinium Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-25 | 1.16 | 1.15 | 1.20 | 1.12 |
| Feb-26 | 1.14 | 1.11 | 1.16 | 1.11 |
| Feb-27 | 1.10 | 1.10 | 1.15 | 1.10 |
| Feb-28 | 1.11 | 1.15 | 1.16 | 1.09 |
| Mar-3 | 1.17 | 1.06 | 1.17 | 1.06 |
| Mar-4 | 1.06 | 1.10 | 1.12 | 1.03 |
| Mar-5 | 1.14 | 1.15 | 1.16 | 1.08 |
| Mar-6 | 1.14 | 1.14 | 1.15 | 1.12 |
| Mar-7 | 1.13 | 1.14 | 1.14 | 1.10 |
| Mar-11 | 1.11 | 1.15 | 1.15 | 1.09 |
| Mar-12 | 1.17 | 1.15 | 1.17 | 1.12 |
| Mar-13 | 1.17 | 1.20 | 1.22 | 1.16 |
| Mar-14 | 1.24 | 1.23 | 1.26 | 1.21 |
| Mar-17 | 1.26 | 1.30 | 1.30 | 1.23 |
Actinium Pharmaceuticals Earnings
Data Unavailable
Actinium Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.32 per share.
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.